Lilly trained its sales force to downplay Zyprexa's risks

Eli Lilly & Co. trained its sales force to downplay risks for Zyprexa and encourage doctors to prescribe the drug beyond approved uses for schizophrenia and bipolar disorder, according to court documents.
Read article at bloomberg.com